Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Shares Outstanding (Diluted Average) (2016)

Amphastar Pharmaceuticals (AMPH) has 4 years of Shares Outstanding (Diluted Average) data on record, last reported at $45.7 million in Q2 2016.

  • For Q2 2016, Shares Outstanding (Diluted Average) rose 1.92% year-over-year to $45.7 million; the TTM value through Jun 2016 reached $45.7 million, up 1.92%, while the annual FY2015 figure was $45.0 million, N/A changed from the prior year.
  • Shares Outstanding (Diluted Average) reached $45.7 million in Q2 2016 per AMPH's latest filing, down from $46.8 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $46.8 million in Q1 2016 and bottomed at $38769.0 in Q1 2014.
  • Average Shares Outstanding (Diluted Average) over 4 years is $28.6 million, with a median of $38.9 million recorded in 2013.
  • Peak YoY movement for Shares Outstanding (Diluted Average): tumbled 99.9% in 2014, then soared 114942.95% in 2015.
  • A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $38.9 million in 2013, then tumbled by 99.89% to $44644.0 in 2014, then soared by 100610.06% to $45.0 million in 2015, then rose by 1.67% to $45.7 million in 2016.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Diluted Average) were $45.7 million in Q2 2016, $46.8 million in Q1 2016, and $45.0 million in Q4 2015.